US 10022319 — Patent Expiration

Stabilized Antibody-Containing Liquid Formulations

Shareable link — bookmark or send to anyone

www.patentreply.ai/tools/patent-expiration/US10022319

Important: This calculator does not include patent term extension under 35 U.S.C. § 156, which may apply to certain drug, biologic, animal drug, and medical device patents.

Learn how PTE is calculated

US 10022319

Stabilized Antibody-containing Liquid Formulations

High Confidence

Application No. 13522848

September 5, 2031

5y 3d remaining

Could not fetch continuity data for application PCTJP2011050911: Resource not found (404)

Earliest effective filing

Jan 20, 2011

+ 20 years

Jan 20, 2031

PTA +228d

Sep 5, 2031

No TD

—

Final

Sep 5, 2031

This calculation includes Patent Term Adjustment (PTA) under 35 U.S.C. §154(b). Patent Term Extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation Details

Base Term Calculation

Filing Date

October 2, 2012

Earliest Effective Filing

January 20, 2011

Issue Date

July 17, 2018

PTA

+228 days

Base Expiry (before PTA)

January 20, 2031

January 20, 2011 + 20 years = January 20, 2031 + 228 PTA days = September 5, 2031

National Stage Entry of application PCTJP2011050911, filed Jan 20, 2011

Terminal Disclaimer Analysis

No TD

0 approved, 0 filed

Who owns this patent?

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.